Latest Articles

Publication Date
Hormone ‘fingerprint’ found in endometriosis - The Star

Hormone ‘fingerprint’ found in endometriosis The Star

Published: July 23, 2026, noon
Fampridine: NHS England Rolls Out First Multiple Sclerosis Drug To Improve Walking - Health and Me

Fampridine: NHS England Rolls Out First Multiple Sclerosis Drug To Improve Walking Health and Me

Published: July 23, 2026, 11:30 a.m.
Recurrent IVF Failure isn’t the End of Journey ; Personalised Treatment is Improving Success Rates: Fertility Experts - 5 Dariya News

Recurrent IVF Failure isn’t the End of Journey ; Personalised Treatment is Improving Success Rates: Fertility Experts 5 Dariya News

Published: July 23, 2026, 7:34 a.m.
Roborock Qrevo S Pro deal: Save $150 at Amazon - Mashable

Roborock Qrevo S Pro deal: Save $150 at Amazon Mashable

Published: July 23, 2026, 12:37 a.m.
Longitudinal trends in general, central, and visceral adiposity indices among women with endometriosis: a population-based study.

Previous studies have suggested the close link between endometriosis and body size index. However, there are inconsistent associations between central, general, and visceral adiposity index and endometriosis. This study aimed …

Published: July 23, 2026, midnight
Hierarchical attention and frequency fusion network for endometriotic lesion detection in laparoscopic images.

Endometriosis is a common gynecological disorder that requires accurate detection of ectopic lesions in laparoscopic images for effective diagnosis and treatment. However, existing deep learning-based detection methods face significant challenges …

Published: July 23, 2026, midnight
Cancer Risk Profile of the Levonorgestrel-Releasing Intrauterine Device: A Narrative Review.

Background/Objectives: The levonorgestrel-releasing intrauterine device (LNG-IUD) is widely used as a long-acting reversible contraceptive and as a therapeutic option for heavy menstrual bleeding, endometriosis, adenomyosis, and endometrial hyperplasia. Although its …

Published: July 23, 2026, midnight
Glycolytic Reprogramming in Endometriosis: Biological Basis and Emerging Targets for Disease-Modifying Therapy.

Endometriosis is a chronic gynecological disease affecting approximately 10% of women of reproductive age and up to 40% of women with infertility, with a significant impact on quality of life …

Published: July 23, 2026, midnight
Perceived Access to Endometriosis Care Among Hispanic Women: A Cross-Sectional Survey.

Primary objective We evaluated perceived access to endometriosis-related care among Hispanic and non-Hispanic women with endometriosis. Secondary objectives We compared referral experiences, financial barriers, geographic access, and specialist access between …

Published: July 23, 2026, midnight
The Therapeutic Role of Dienogest in Endometriosis-Associated Pain: From Basics to Clinics.

The most common symptom of endometriosis is pain. The pathogenesis of endometriosis-associated pain remains unclear. In this review, we illustrate the pathogenesis of endometriosis-associated pain and the mechanisms of dienogest …

Published: July 23, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!